市場調査レポート
商品コード
1347561
不妊治療機器市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測Infertility Treatment Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
不妊治療機器市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測 |
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界の不妊治療機器市場規模は、2022年に4億2,470万米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて6.11%の成長率(CAGR)を示し、2028年までに6億890万米ドルに達すると予測しています。
不妊症とは、男性または女性の生殖器官の疾患で、12カ月以上経っても妊娠に至らないものです。一般に、男性生殖系では精液の排出に問題があること、女性生殖系では卵巣、子宮、卵管、内分泌系に異常があることが原因です。体外受精(IVF)や顕微授精(ICSI)などの生殖補助医療(ART)や、子宮内人工授精(IUI)などの人工授精法を用いて治療されます。現在、世界中で多嚢胞性卵巣症候群(PCOS)などの有病率が上昇していることから、不妊治療機器の需要が増加しています。
世界中で不妊治療クリニックの数が増加していることは、市場の成長を促進する重要な要因の一つです。また、座りっぱなしの生活習慣による運動不足が、糖尿病、肥満、高血圧などの慢性疾患の発症につながっており、これらは男女の不妊につながる潜在的な危険因子となっています。その結果、凍結胚やドナー卵子・精子を利用する体外受精などのARTの利用が増加しています。このことは、多数の不妊治療機器が利用可能になりつつあることと相まって、市場にプラスの影響を与えています。これとは別に、主なプレーヤーは技術の進歩を導入し、妊娠成功率を向上させる技術を開発しています。また、存在感を高め、顧客基盤を拡大するために、戦略的開発、国内プレイヤーとの契約/提携、地理的拡大、M&A(合併・買収)にますます注力しています。市場成長に寄与するその他の要因としては、出生率の低下、官民投資の増加、不妊治療へのアクセス性を高めるための政府の取り組みなどが挙げられます。
The global infertility treatment devices market size reached US$ 424.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 608.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.
Infertility is a disease of the male or female reproductive system wherein attempts to achieve pregnancy after 12 months or more fail. It is generally caused by problems in the ejection of semen in the male reproductive system or abnormalities in the ovaries, uterus, fallopian tubes, and the endocrine system of the female reproductive system. It is treated using assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), and artificial insemination methods like intrauterine insemination (IUI). At present, there is a rise in the demand for infertility treatment devices on account of the rising prevalence of conditions like polycystic ovary syndrome (PCOS) around the world.
The increasing number of fertility clinics across the globe represents one of the key factors propelling the growth of the market. Moreover, lack of physical activities on account of sedentary lifestyles has led to the development of chronic diseases, such as diabetes, obesity, and hypertension, which are potential risk factors leading to infertility among men and women. Consequently, there is a rise in the use of ART procedures, such as IVF, which involves the utilization of previously frozen embryos and donor eggs or sperm. This, coupled with the growing availability of numerous infertility treatment devices, is positively influencing the market. Apart from this, key players are introducing technological advancements and developing techniques that improve the conception success rate. They are also increasingly focusing on strategic developments, agreements/partnerships with domestic players, geographical expansions, and mergers and acquisitions (M&A) to increase their presence and widen their customer-base. Some of the other factors contributing to the market growth include declining fertility rates, rising public-private investments and government initiatives to increase the accessibility of infertility treatments.
IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility treatment devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, patient type and end user.
Sperm Separation Devices
Ovum Aspiration Pumps
Sperm Analyzer Systems
Micromanipulator Systems
Incubators
Cryosystems
Imaging Systems
Microscopes
Others
Female Infertility Treatment
Male Infertility Treatment
Fertility Clinics
Hospitals and Other Healthcare Facilities
Clinical Research Institutes
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Scientific Ltd, Cook Group Incorporated, Coopersurgical Inc. (The Cooper Companies Inc.), Eppendorf, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne Ltd., Kitazato Corporation, Rocket Medical plc, Thermo Fisher Scientific, Thomas Medical (Medgyn Products Inc.), Vitrolife.